Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
TCR1188-ABC Cells in KRAS-mutated Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
- Status
- RECRUITING
- Phase
- PHASE3
Neutralizing Interleukin (IL)-6
- Status
- RECRUITING
- Phase
- PHASE2
RCT of Tocilizumab for Anti-MDA5+DM
- Status
- RECRUITING
- Phase
- NA
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE3
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2
- Status
- RECRUITING
- Phase
- PHASE3
Tocilizumab in Chronic Inflammatory CPPD Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE1
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
- Status
- RECRUITING
- Phase
- PHASE2
Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
- Status
- RECRUITING
- Phase
- NA
An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1